TreeFrog’s CEO/CTO cited in Labiotech.eu
Kevin Alessandri, CEO/CTO of TreeFrog was cited in a recent article of Labiotech.eu on the current obstacles preventing cell therapies to become mainstream. Read more...
29 May, 2019 News Press
We have developed C-STEMTM : a proprietary technology for the mass-production of cell therapies.
Our offer
Cell therapy pipeline
A series of proprietary cell therapy programs for co-development or licensing
Latest news
-
-
A full page in BiotechFinances !
We are glad of this coverage in the print edition of BiotechFinances. Check the online version here....
20 May, 2019 News Press -
I am test text for Image with text shortcode. |
TreeFrog Therapeutics I Stem Cell Company I Cell Therapy for all
TreeFrog Therapeutics is a French stem cell company aiming at supporting the advent and industrial development of stem cell therapies.